From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

GOTCHA: Lying Charlatans at Argent Pharma flip flop on delisting, shares collapse, TW 100% vindicated yet again

By Tom Winnifrith | Friday 29 November 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Shares in Argent Pharma (RGT) have collapsed to 8.5p after a dramatic flip fop on its delisting plans. I told you that this company was a worthless piece of crap run by charlatans when its stock was a consolidation adjusted 225p on January 11 2022. How they all protested. TW knows nothing, TW is batting for diseases affecting the CNS, yadda yadda yadda. *Ouzo on cornflakes time again.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Friday »

VLG

Venture Life Group – growth value: BUY

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

 

PICH

Pitch Pit – this stinks

 

GEX

Georgina Energy: Lyin’ Yet again

Time left: 11:29:09